Literature DB >> 34303328

The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.

Siva Dallavalasa1, Narasimha M Beeraka1, Chaithanya G Basavaraju1, SubbaRao V Tulimilli1, Surya Prabha Sadhu2, Konathala Rajesh3, Gjumrakch Aliev4, SubbaRao V Madhunapantula1.   

Abstract

Tumor associated macrophages (TAMs), located in the tumor microenvironment (TME), play a significant role in cancer cell survival and progression. TAMs have been involved in producing immuno-suppressive TME in the tumor by generating inflammatory mediators, growth factors, cytokines, chemokines, etc. TAMs can influence the angiogenesis, metastatic behavior of tumor cells (TCs) and cause multidrug resistance. TAMs within the TME can enhance cancer cell metastasis and are stromal and perivascular. The angiogenesis is promoted at the hypoxia, and the avascular zones of TME. Differentiation states of TAMs are considered 'plastic' as they exhibit temporal expression of one or several phenotypes depending on local cues. Emerging cancer research depicted the epigenetic regulation of macrophage polarization (both M1s, M2s) and their potential implications to develop pharmacologic modulators and microRNAs to act as molecular switches and even to serve as targeted therapies to inhibit tumor growth. In the present article, the role of TAMs in tumor progression, angiogenesis and metastasis was discussed. In addition, key signaling cascades regulated by TAMs, which have a role in chemoresistance, were also discussed. Currently, novel pleiotropic properties of various anticancer phytomedicines are gaining importance as they assist in overcoming TAMs-induced chemoresistance. Moreover, these phytomedicines are being tested as 'adjunct therapeutics' along with chemotherapeutic agents, anti-angiogenic molecules, anti-metastatic compounds, and other immune-checkpoint blockers against tumor metastasis/angiogenesis. Hence, a brief note on natural products targeting TAMs was provided. In summary, this review would benefit pharmacologists and medical professionals to develop therapies to target TAMs using multi-OMICs approaches, including genomics, epigenomics, transcriptomics, and proteomics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  M1 and M2; Tumor associated macrophages; chemosensitization; macrophages; natural products.; tumor angiogenesis; tumor microenvironment

Mesh:

Year:  2021        PMID: 34303328     DOI: 10.2174/0929867328666210720143721

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  7 in total

1.  Advances in the Prevention and Treatment of Obesity-Driven Effects in Breast Cancers.

Authors:  Kuo Chen; Jin Zhang; Narasimha M Beeraka; Chengyun Tang; Yulia V Babayeva; Mikhail Y Sinelnikov; Xinliang Zhang; Jiacheng Zhang; Junqi Liu; Igor V Reshetov; Olga A Sukocheva; Pengwei Lu; Ruitai Fan
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 2.  Tumor-associated macrophages: An important player in breast cancer progression.

Authors:  Xinqun Huang; Jingsong Cao; Xuyu Zu
Journal:  Thorac Cancer       Date:  2021-12-15       Impact factor: 3.500

3.  Cisplatin resistance-related multi-omics differences and the establishment of machine learning models.

Authors:  Qihai Sui; Zhencong Chen; Zhengyang Hu; Yiwei Huang; Jiaqi Liang; Guoshu Bi; Yunyi Bian; Mengnan Zhao; Cheng Zhan; Zongwu Lin; Qun Wang; Lijie Tan
Journal:  J Transl Med       Date:  2022-04-11       Impact factor: 5.531

4.  Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages.

Authors:  Jincheng Wang; Jialu Jin; Ting Chen; Qian Zhou
Journal:  Molecules       Date:  2022-07-06       Impact factor: 4.927

Review 5.  Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report.

Authors:  Clelia Madeddu; Elisabetta Sanna; Sonia Nemolato; Olga Mulas; Sara Oppi; Mario Scartozzi; Giorgio La Nasa; Antonio Maccio
Journal:  Diagnostics (Basel)       Date:  2022-08-07

Review 6.  Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development.

Authors:  Weihua Yu; Yongmei Tu; Zi Long; Jiangzheng Liu; Deqin Kong; Jie Peng; Hao Wu; Gang Zheng; Jiuzhou Zhao; Yuhao Chen; Rui Liu; Wenli Li; Chunxu Hai
Journal:  Oxid Med Cell Longev       Date:  2022-06-28       Impact factor: 7.310

7.  lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer.

Authors:  Aitao Nai; Huihui Zeng; Qiong Wu; Zirui He; Shuwen Zeng; Shoaib Bashir; Feng Ma; Jie He; Wei Wan; Meng Xu
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.